30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

enVVeno Medical Corp (NVNO)

Track

Over the last 90 days, enVVeno Medical Corp. has seen one insider transaction, a sale totaling $1,443.00. This contrasts with earlier periods showing multiple buy transactions from executives and directors. The company's stock has experienced a 3.2% decrease over the past 90 days, trading near its 52-week low.
Stock chart
Ticker: NVNO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Duhay Francis
2 sales — total 200,000 USD
Planned sale 11 Jun 2026
Value US$836,932.59 | Price 183.52 | Shares 78,748
Proposed sale 11 Jun 2026
Value US$4,644,415.41 | Price 188.96 | Shares 83,069
Planned sale 12 Mar 2026
Value US$4,573,039.97 | Price 370.90 | Shares 62,018
Proposed sale 12 Mar 2026
Value US$1,018,601.76 | Price 326.99 | Shares 91,533
Planned sale 11 Dec 2025
Value US$1,742.44 | Price 0.36 | Shares 4,900
Planned sale 15 Sep 2025
Value US$4,067.00 | Price 0.83 | Shares 4,900
Proposed sale 15 Sep 2025
Value US$8,143.00 | Price 0.83 | Shares 9,800
Buy 31 Dec 2024
Value US$249,999.31 | Price 3.07 | Shares 81,433
Buy 31 Dec 2024
Value US$10,290.00 | Price 2.94 | Shares 3,500
Buy 24 Dec 2024
Value US$15,660.00 | Price 2.90 | Shares 5,400
Buy 19 Dec 2024
Value US$24,338.60 | Price 2.53 | Shares 9,620
Buy 19 Dec 2024
Value US$30,600.00 | Price 2.55 | Shares 12,000
Sale 13 Mar 2024
Value US$51,837.48 | Price 6.22 | Shares 8,334
Buy 16 Aug 2022
Value US$47,591.14 | Price 6.14 | Shares 7,751
Buy 30 Jun 2022
Value US$3,850.00 | Price 3.85 | Shares 1,000
Buy 27 Jun 2022
Value US$9,500.00 | Price 3.80 | Shares 2,500
Buy 19 Nov 2021
Value US$14,860.00 | Price 7.43 | Shares 2,000
Buy 16 Nov 2021
Value US$15,740.00 | Price 7.87 | Shares 2,000
Buy 16 Jun 2021
Value US$12,500.00 | Price 6.25 | Shares 2,000
Buy 21 May 2021
Value US$9,440.00 | Price 5.90 | Shares 1,600
Buy 18 May 2021
Value US$16,410.00 | Price 5.47 | Shares 3,000
Sale 21 Aug 2020
Value US$28,500.00 | Price 0.38 | Shares 75,000
Sale 20 Aug 2020
Value US$20,250.00 | Price 0.27 | Shares 75,000
Sale 19 Aug 2020
Value US$15,000.00 | Price 0.30 | Shares 50,000
Sale 18 Aug 2020
Value US$17,000.00 | Price 0.34 | Shares 50,000
Sale 14 Aug 2020
Value US$15,500.00 | Price 0.31 | Shares 50,000
Sale 3 Aug 2020
Value US$22,400.00 | Price 0.32 | Shares 70,000
Sale 31 Jul 2020
Value US$1,700.00 | Price 0.34 | Shares 5,000
Sale 30 Jul 2020
Value US$8,000.00 | Price 0.32 | Shares 25,000
Sale 21 Jul 2020
Value US$22,500.00 | Price 0.45 | Shares 50,000
Sale 20 Jul 2020
Value US$64,500.00 | Price 0.43 | Shares 150,000
Sale 17 Jul 2020
Value US$19,000.00 | Price 0.38 | Shares 50,000
Sale 16 Jul 2020
Value US$19,000.00 | Price 0.38 | Shares 50,000
Sale 6 Jul 2020
Value US$2,515.50 | Price 0.39 | Shares 6,450
Sale 2 Jul 2020
Value US$22,800.00 | Price 0.40 | Shares 57,000
Sale 1 Jul 2020
Value US$17,100.00 | Price 0.38 | Shares 45,000
Sale 29 Jun 2020
Value US$26,556.66 | Price 0.39 | Shares 68,094
Sale 26 Jun 2020
Value US$30,400.00 | Price 0.38 | Shares 80,000
Sale 25 Jun 2020
Value US$40,000.00 | Price 0.40 | Shares 100,000
Sale 24 Jun 2020
Value US$23,322.60 | Price 0.42 | Shares 55,530
Sale 23 Jun 2020
Value US$34,400.00 | Price 0.43 | Shares 80,000
Sale 22 Jun 2020
Value US$29,065.56 | Price 0.46 | Shares 63,186
Sale 19 Jun 2020
Value US$36,800.00 | Price 0.46 | Shares 80,000
Sale 18 Jun 2020
Value US$27,738.00 | Price 0.45 | Shares 61,640
Sale 17 Jun 2020
Value US$97,488.00 | Price 0.48 | Shares 203,100
Sale 16 Jun 2020
Value US$64,500.00 | Price 0.43 | Shares 150,000
Sale 15 Jun 2020
Value US$42,000.00 | Price 0.42 | Shares 100,000
Sale 11 Jun 2020
Value US$39,000.00 | Price 0.39 | Shares 100,000
Sale 3 Jun 2020
Value US$521.73 | Price 0.31 | Shares 1,683
Sale 3 Jun 2020
Value US$1,209.00 | Price 0.31 | Shares 3,900
Sale 2 Jun 2020
Value US$72,600.00 | Price 0.33 | Shares 220,000
Sale 7 Jun 2019
Value US$458,824.71 | Price 0.67 | Shares 684,813
Buy 12 Mar 2019
Value US$25,001.00 | Price 1.15 | Shares 21,740
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-11 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
78,748 +41.9%
183.52
US$836,933 		78,748 +41.9% 183.52 US$836,933
2026-06-11 2026-06-11 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
83,069
188.96
US$4,644,415 		83,069 188.96 US$4,644,415
2026-03-13 2026-03-12 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
62,018 -38.4%
370.90
US$4,573,040 		62,018 -38.4% 370.90 US$4,573,040
2026-03-12 2026-03-12 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
140
11.52
US$1,613 		140 11.52 US$1,613
2025-12-12 2025-12-11 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
4,900 -5.0%
0.36
US$1,742 		4,900 -5.0% 0.36 US$1,742
2025-09-17 2025-09-15 PlS Planned sale
2.2
Duhay Francis
Non-Executive Director
4,900 -4.8%
0.83
US$4,067 		4,900 -4.8% 0.83 US$4,067
2025-09-15 2025-09-15 PrS Proposed sale
2.2
Duhay Francis

Director

Non-Executive Director
9,800
0.83
US$8,143 		9,800 0.83 US$8,143
2025-01-03 2024-12-31 B Purchase
2.2
Duhay Francis
Non-Executive Director
81,433 +389.4%
3.07
US$249,999 		81,433 +389.4% 3.07 US$249,999
2025-01-02 2024-12-31 B Purchase
3.1
Gray Robert
Non-Executive Director
3,500 +45.7%
2.94
US$10,290 		3,500 +45.7% 2.94 US$10,290
2024-12-26 2024-12-24 B Purchase
3.3
Shrivastava Sanjay
Non-Executive Director
5,400 +138.9%
2.90
US$15,660 		5,400 +138.9% 2.90 US$15,660
2024-12-23 2024-12-19 B Purchase
2.5
Jenusaitis Matthew
Non-Executive Director
9,620 +138.9%
2.53
US$24,339 		9,620 +138.9% 2.53 US$24,339
2024-12-19 2024-12-19 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
12,000 +5.7%
2.55
US$30,600 		12,000 +5.7% 2.55 US$30,600
2024-03-15 2024-03-13 S Sale
3.1
Alavi Hamed

Chief Technology Officer

Officer
8,334 -100.0%
6.22
US$51,837 		8,334 -100.0% 6.22 US$51,837
2022-08-18 2022-08-16 B Purchase
2.2
Duhay Francis
Non-Executive Director
7,751 +58.9%
6.14
US$47,591 		7,751 +58.9% 6.14 US$47,591
2022-07-01 2022-06-30 B Purchase
3.3
Shrivastava Sanjay
Non-Executive Director
1,000 +34.6%
3.85
US$3,850 		1,000 +34.6% 3.85 US$3,850
2022-06-28 2022-06-27 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
2,500 +1.2%
3.80
US$9,500 		2,500 +1.2% 3.80 US$9,500
2021-11-19 2021-11-19 B Purchase
3.3
BERMAN ROBERT ANDREW

CEO

Executive Director
2,000 +34.9%
7.43
US$14,860 		2,000 +34.9% 7.43 US$14,860
2021-11-18 2021-11-16 B Purchase
3.3
BERMAN ROBERT ANDREW

CEO

Officer
2,000 +53.5%
7.87
US$15,740 		2,000 +53.5% 7.87 US$15,740
2021-06-21 2021-06-16 B Purchase
3.1
Gray Robert
Non-Executive Director
2,000 +56.0%
6.25
US$12,500 		2,000 +56.0% 6.25 US$12,500
2021-05-25 2021-05-21 B Purchase
3.0
Glickman Marc H.

SVP & Chief Medical Officer

Officer
1,600 +inf%
5.90
US$9,440 		1,600 +inf% 5.90 US$9,440
2021-05-19 2021-05-18 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
3,000 +407.6%
5.47
US$16,410 		3,000 +407.6% 5.47 US$16,410
2020-10-01 2020-08-21 S Sale
3.1
Biodyne Holding, S.A.
75,000 -5.1%
0.38
US$28,500 		75,000 -5.1% 0.38 US$28,500
2020-10-01 2020-08-20 S Sale
3.1
Biodyne Holding, S.A.
75,000 -4.8%
0.27
US$20,250 		75,000 -4.8% 0.27 US$20,250
2020-10-01 2020-08-19 S Sale
3.1
Biodyne Holding, S.A.
50,000 -3.1%
0.30
US$15,000 		50,000 -3.1% 0.30 US$15,000
2020-10-01 2020-08-18 S Sale
3.1
Biodyne Holding, S.A.
50,000 -3.0%
0.34
US$17,000 		50,000 -3.0% 0.34 US$17,000
2020-10-01 2020-08-14 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.9%
0.31
US$15,500 		50,000 -2.9% 0.31 US$15,500
2020-10-01 2020-08-03 S Sale
3.1
Biodyne Holding, S.A.
70,000 -3.9%
0.32
US$22,400 		70,000 -3.9% 0.32 US$22,400
2020-10-01 2020-07-31 S Sale
3.1
Biodyne Holding, S.A.
5,000 -0.3%
0.34
US$1,700 		5,000 -0.3% 0.34 US$1,700
2020-10-01 2020-07-30 S Sale
3.1
Biodyne Holding, S.A.
25,000 -1.4%
0.32
US$8,000 		25,000 -1.4% 0.32 US$8,000
2020-10-01 2020-07-21 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.7%
0.45
US$22,500 		50,000 -2.7% 0.45 US$22,500
2020-10-01 2020-07-20 S Sale
3.1
Biodyne Holding, S.A.
150,000 -7.5%
0.43
US$64,500 		150,000 -7.5% 0.43 US$64,500
2020-10-01 2020-07-17 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.4%
0.38
US$19,000 		50,000 -2.4% 0.38 US$19,000
2020-10-01 2020-07-16 S Sale
3.1
Biodyne Holding, S.A.
50,000 -2.4%
0.38
US$19,000 		50,000 -2.4% 0.38 US$19,000
2020-10-01 2020-07-06 S Sale
3.1
Biodyne Holding, S.A.
6,450 -0.3%
0.39
US$2,516 		6,450 -0.3% 0.39 US$2,516
2020-10-01 2020-07-02 S Sale
3.1
Biodyne Holding, S.A.
57,000 -2.6%
0.40
US$22,800 		57,000 -2.6% 0.40 US$22,800
2020-10-01 2020-07-01 S Sale
3.1
Biodyne Holding, S.A.
45,000 -2.0%
0.38
US$17,100 		45,000 -2.0% 0.38 US$17,100
2020-10-01 2020-06-29 S Sale
3.1
Biodyne Holding, S.A.
68,094 -3.0%
0.39
US$26,557 		68,094 -3.0% 0.39 US$26,557
2020-10-01 2020-06-26 S Sale
3.1
Biodyne Holding, S.A.
80,000 -3.4%
0.38
US$30,400 		80,000 -3.4% 0.38 US$30,400
2020-10-01 2020-06-25 S Sale
3.1
Biodyne Holding, S.A.
100,000 -4.1%
0.40
US$40,000 		100,000 -4.1% 0.40 US$40,000
2020-10-01 2020-06-24 S Sale
3.1
Biodyne Holding, S.A.
55,530 -2.2%
0.42
US$23,323 		55,530 -2.2% 0.42 US$23,323
2020-10-01 2020-06-23 S Sale
3.1
Biodyne Holding, S.A.
80,000 -3.1%
0.43
US$34,400 		80,000 -3.1% 0.43 US$34,400
2020-10-01 2020-06-22 S Sale
3.1
Biodyne Holding, S.A.
63,186 -2.4%
0.46
US$29,066 		63,186 -2.4% 0.46 US$29,066
2020-10-01 2020-06-19 S Sale
3.1
Biodyne Holding, S.A.
80,000 -2.9%
0.46
US$36,800 		80,000 -2.9% 0.46 US$36,800
2020-10-01 2020-06-18 S Sale
3.1
Biodyne Holding, S.A.
61,640 -2.2%
0.45
US$27,738 		61,640 -2.2% 0.45 US$27,738
2020-10-01 2020-06-17 S Sale
3.1
Biodyne Holding, S.A.
203,100 -6.8%
0.48
US$97,488 		203,100 -6.8% 0.48 US$97,488
2020-10-01 2020-06-16 S Sale
3.1
Biodyne Holding, S.A.
150,000 -4.8%
0.43
US$64,500 		150,000 -4.8% 0.43 US$64,500
2020-10-01 2020-06-15 S Sale
3.1
Biodyne Holding, S.A.
100,000 -3.1%
0.42
US$42,000 		100,000 -3.1% 0.42 US$42,000
2020-10-01 2020-06-11 S Sale
3.1
Biodyne Holding, S.A.
100,000 -3.0%
0.39
US$39,000 		100,000 -3.0% 0.39 US$39,000
2020-06-08 2020-06-03 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
1,683 -0.1%
0.31
US$522 		1,683 -0.1% 0.31 US$522
2020-06-08 2020-06-03 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
3,900 -0.1%
0.31
US$1,209 		3,900 -0.1% 0.31 US$1,209
2020-06-08 2020-06-02 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
220,000 -6.1%
0.33
US$72,600 		220,000 -6.1% 0.33 US$72,600
2020-05-14 2019-06-07 S Sale
3.1
Biodyne Holding, S.A.
Large shareholder
684,813 -16.1%
0.67
US$458,825 		684,813 -16.1% 0.67 US$458,825
2019-03-14 2019-03-12 B Purchase
3.3
BERMAN ROBERT ANDREW

Chief Executive Officer

Executive Director
21,740 +inf%
1.15
US$25,001 		21,740 +inf% 1.15 US$25,001
Explore more

More insider trading research around enVVeno Medical Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America